System-wide implementation of the use of an extended-infusion piperacillin/tazobactam dosing strategy: feasibility of utilization from a children's hospital perspective

KR Nichols, CA Knoderer, EG Cox, MB Kays - Clinical therapeutics, 2012 - Elsevier
BACKGROUND: Use of extended infusions of piperacillin/tazobactam (PT) in adult patients
has been described, but data in children are limited. OBJECTIVE: The goal of this study was …

Implementation of an extended-infusion piperacillin–tazobactam program at an urban teaching hospital

RC Xamplas, GS Itokazu, RC Glowacki… - American Journal of …, 2010 - academic.oup.com
Purpose The development and implementation of an extended-infusion piperacillin–
tazobactam program at an urban teaching hospital are described. Summary A …

Extended infusion of piperacillin/tazobactam in children

CA Knoderer, LC Karmire… - The Journal of …, 2017 - meridian.allenpress.com
OBJECTIVES Extended-infusion piperacillin/tazobactam (TZP) has been associated with
positive clinical outcomes in adults, but similar data in children are lacking. The objective of …

[HTML][HTML] Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in …

T Chongcharoenyanon, N Wacharachaisurapol… - International Journal of …, 2021 - Elsevier
Objectives To be effective, piperacillin/tazobactam (PTZ) unbound plasma levels need to be
above the minimum inhibitory concentration (MIC) at least 50% of the time between dosing …

Population pharmacokinetics and safety of piperacillin-tazobactam extended infusions in infants and children

C Thibault, J Lavigne, C Litalien, N Kassir… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Piperacillin-tazobactam (TZP) is frequently used to treat severe hospital-acquired infections
in children. We performed a single-center, pharmacokinetic (PK) trial of TZP in children …

Dose optimization of piperacillin/tazobactam in critically ill children

PAJG De Cock, SC Van Dijkman… - Journal of …, 2017 - academic.oup.com
Objectives: To characterize the population pharmacokinetics of piperacillin and tazobactam
in critically ill infants and children, in order to develop an evidence-based dosing regimen …

Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Population pharmacokinetics of piperacillin/tazobactam in critically ill young children

JJ Cies, V Shankar, C Schlichting… - The Pediatric infectious …, 2014 - journals.lww.com
Methods: Blood samples (2–4 per child) were collected from 13 children ages 9 months to 6
years admitted to the pediatric intensive care unit who were receiving standard piperacillin …

Outcomes of an extended-infusion piperacillin-tazobactam protocol implementation in a community teaching hospital adult intensive care unit

PM Schmees, SJ Bergman, BD Strader… - American Journal of …, 2016 - academic.oup.com
Objective The purpose of this study is to evaluate the outcome differences between patients
receiving piperacillin-tazobactam pre-and post-implementation of an extended infusion …

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

GT Mah, VH Mabasa, I Chow… - Annals of …, 2012 - journals.sagepub.com
Objective: To perform a qualitative systematic review of the evidence comparing traditional
strategies against prolonged intermittent or continuous infusion strategies for piperacillin …